Phase II trial of mitomycin C plus 5-FU in the treatment of drug-refractory ovarian cancer

David S. Alberts, Dava Garcia-Kendall, Earl A. Surwit

Research output: Contribution to journalArticlepeer-review

14 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II trial of mitomycin C plus 5-FU in the treatment of drug-refractory ovarian cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences